$NWBO
NORTHWEST BIOTHERAPEUTICS INC

2022 Q4 Form 10-Q Financial Statement

#000141057822003073 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $597.0K $206.0K
YoY Change -41.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.423M $8.130M
YoY Change 45.19% 22.24%
% of Gross Profit
Research & Development $9.352M $7.694M
YoY Change 123.41% 105.28%
% of Gross Profit
Depreciation & Amortization $318.0K $310.0K
YoY Change 278.57% 226.32%
% of Gross Profit
Operating Expenses $18.78M $7.694M
YoY Change 75.86% 105.28%
Operating Profit -$15.62M
YoY Change 55.42%
Interest Expense -$7.585M $1.512M
YoY Change -105.25% -5.74%
% of Operating Profit
Other Income/Expense, Net -$17.23M
YoY Change -131.01%
Pretax Income -$28.30M -$32.85M
YoY Change -121.23% -172.17%
Income Tax
% Of Pretax Income
Net Earnings -$28.30M -$32.85M
YoY Change -121.23% -172.17%
Net Earnings / Revenue -4740.03% -15947.57%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03 -$0.03
COMMON SHARES
Basic Shares Outstanding 1.053B 1.041M
Diluted Shares Outstanding 1.041M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.965M $9.425M
YoY Change -54.08% 145.7%
Cash & Equivalents $6.965M $9.425M
Short-Term Investments
Other Short-Term Assets $2.460M $2.339M
YoY Change 15.98% -5.42%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.425M $11.76M
YoY Change -45.49% 86.46%
LONG-TERM ASSETS
Property, Plant & Equipment $13.42M $13.13M
YoY Change -10.71% 938.45%
Goodwill $626.0K $626.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $345.0K $339.0K
YoY Change -66.7% -67.81%
Total Long-Term Assets $21.90M $19.33M
YoY Change -4.25% -11.77%
TOTAL ASSETS
Total Short-Term Assets $9.425M $11.76M
Total Long-Term Assets $21.90M $19.33M
Total Assets $31.32M $31.10M
YoY Change -22.0% 10.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.64M $13.97M
YoY Change 61.16% 13.91%
Accrued Expenses $354.0K $334.0K
YoY Change 11.67% 9.51%
Deferred Revenue
YoY Change
Short-Term Debt $135.0K $0.00
YoY Change
Long-Term Debt Due $15.40M $20.17M
YoY Change 112.78% 149.78%
Total Short-Term Liabilities $126.0M $116.1M
YoY Change -5.8% -62.82%
LONG-TERM LIABILITIES
Long-Term Debt $5.991M $5.942M
YoY Change -76.18% -51.86%
Other Long-Term Liabilities $4.370M $4.132M
YoY Change -16.38% -21.91%
Total Long-Term Liabilities $10.36M $10.07M
YoY Change -65.9% -42.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $126.0M $116.1M
Total Long-Term Liabilities $10.36M $10.07M
Total Liabilities $136.4M $126.2M
YoY Change -16.93% -61.75%
SHAREHOLDERS EQUITY
Retained Earnings -$1.297B -$1.269B
YoY Change 8.81% -4.27%
Common Stock $1.166B $1.154B
YoY Change 9.19% 12.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$128.1M -$108.9M
YoY Change
Total Liabilities & Shareholders Equity $31.32M $31.10M
YoY Change -22.0% 10.19%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$28.30M -$32.85M
YoY Change -121.23% -172.17%
Depreciation, Depletion And Amortization $318.0K $310.0K
YoY Change 278.57% 226.32%
Cash From Operating Activities -$8.849M -$16.12M
YoY Change -21.31% 129.83%
INVESTING ACTIVITIES
Capital Expenditures $2.160M -$276.0K
YoY Change -239.09% -89.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.160M -$276.0K
YoY Change 39.09% -89.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.35M 16.29M
YoY Change -52.04% 82.58%
NET CHANGE
Cash From Operating Activities -8.849M -16.12M
Cash From Investing Activities -2.160M -276.0K
Cash From Financing Activities 11.35M 16.29M
Net Change In Cash 342.0K -108.0K
YoY Change -96.85% -86.22%
FREE CASH FLOW
Cash From Operating Activities -$8.849M -$16.12M
Capital Expenditures $2.160M -$276.0K
Free Cash Flow -$11.01M -$15.84M
YoY Change 13.58% 266.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001072379
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Security Exchange Name
SecurityExchangeName
NONE
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
948.4
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1051.3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35737
dei Entity Registrant Name
EntityRegistrantName
NORTHWEST BIOTHERAPEUTICS, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3306718
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
497-9024
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NWBO
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1052853970
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9425000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15169000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2339000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2121000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
11764000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
17290000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13126000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15027000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3951000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4889000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1292000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1292000
CY2022Q3 us-gaap Goodwill
Goodwill
626000
CY2021Q4 us-gaap Goodwill
Goodwill
626000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
339000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1036000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
357000
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
19334000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
22870000
CY2022Q3 us-gaap Assets
Assets
31098000
CY2021Q4 us-gaap Assets
Assets
40160000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8237000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6976000
CY2022Q3 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
5728000
CY2021Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
3971000
CY2022Q3 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
135000
CY2021Q4 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
135000
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
20032000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7104000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8012000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8232000
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
73650000
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
106784000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
334000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
317000
CY2021Q4 nwbo Shares Payable Current
SharesPayableCurrent
250000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
116128000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
133769000
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5942000
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
25156000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4132000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5226000
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10074000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
30382000
CY2022Q3 us-gaap Liabilities
Liabilities
126202000
CY2021Q4 us-gaap Liabilities
Liabilities
164151000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1051.3
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
948.4
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1051000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
948000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1152689000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1066873000
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
79000
CY2021Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
79000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1268824000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1192090000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6313000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-108850000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-123991000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31098000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40160000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
206000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
350000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1086000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1005000
CY2022Q3 us-gaap Revenues
Revenues
206000
CY2021Q3 us-gaap Revenues
Revenues
350000
us-gaap Revenues
Revenues
1086000
us-gaap Revenues
Revenues
1005000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7694000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3748000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26159000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16122000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8130000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6651000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23930000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26909000
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15824000
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10399000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
50089000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
43031000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15618000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10049000
us-gaap Operating Income Loss
OperatingIncomeLoss
-49003000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42026000
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-12169000
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
58473000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-15883000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
93536000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-456000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-156000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-144000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1512000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1604000
us-gaap Interest Expense
InterestExpense
4847000
us-gaap Interest Expense
InterestExpense
3858000
CY2021Q3 nwbo Inducement Expense
InducementExpense
314000
nwbo Inducement Expense
InducementExpense
314000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3097000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-987000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-6845000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1388000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17234000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55568000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27731000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
87832000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-32852000
us-gaap Net Income Loss
NetIncomeLoss
-76734000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5956000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
45519000
us-gaap Net Income Loss
NetIncomeLoss
-76734000
us-gaap Net Income Loss
NetIncomeLoss
45806000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-2773000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-836000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-5956000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1186000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30079000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46355000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70778000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46992000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1040982
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
875963
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1001703
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
854276
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1040982
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1135762
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1001703
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1099598
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-91666000
CY2022Q3 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
430000
CY2022Q3 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
2402000
CY2022Q3 nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
1421000
CY2022Q3 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
5281000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3361000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-32852000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2773000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-108850000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-349842000
CY2021Q3 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
8035000
CY2021Q3 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
23018000
CY2021Q3 nwbo Adjustments To Additional Paid In Capital Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise
4000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1263000
CY2021Q3 nwbo Adjustment To Additional Paid In Capital Reclassification Of Warrant Liabilities Based On Authorized Shares
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantLiabilitiesBasedOnAuthorizedShares
30566000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
45519000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
836000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-301733000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-123991000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9689000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
9986000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
22090000
nwbo Adjustments To Additional Paid In Capital Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise
26800000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
7613000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9741000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-108850000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-362948000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24462000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
7500000
nwbo Value Of Warrants And Stock Options Exercised For Cash
ValueOfWarrantsAndStockOptionsExercisedForCash
12108000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
34412000
nwbo Adjustments To Additional Paid In Capital Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise
1596000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14705000
nwbo Adjustment To Additional Paid In Capital Reclassification Of Warrant Liabilities Based On Authorized Shares
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantLiabilitiesBasedOnAuthorizedShares
56114000
us-gaap Net Income Loss
NetIncomeLoss
45806000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1186000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-301733000
us-gaap Net Income Loss
NetIncomeLoss
-76734000
us-gaap Net Income Loss
NetIncomeLoss
45806000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
934000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
240000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
2111000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
1721000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-15883000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
93536000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-156000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-144000
nwbo Inducement Expense
InducementExpense
314000
nwbo Operating Lease Roa
OperatingLeaseRoa
184000
nwbo Operating Lease Roa
OperatingLeaseRoa
206000
us-gaap Share Based Compensation
ShareBasedCompensation
9741000
us-gaap Share Based Compensation
ShareBasedCompensation
14632000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
29009000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-76279000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
310000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-3113000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
-633000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
198000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1251000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2351000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
2127000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-1845000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
98000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43926000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27053000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
742000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
4462000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-742000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4462000
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
9465000
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
16000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9986000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12108000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5600000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
13574000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
767000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5390000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2003000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30617000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14632000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8307000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
906000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5744000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6147000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15169000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9983000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9425000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3836000
nwbo Stock Issued During Period Value For Warrant And Stock Options Cashless Exercise
StockIssuedDuringPeriodValueForWarrantAndStockOptionsCashlessExercise
34000
nwbo Stock Issued During Period Value For Warrant And Stock Options Cashless Exercise
StockIssuedDuringPeriodValueForWarrantAndStockOptionsCashlessExercise
7000
nwbo Reclassification Of Warrant Liabilities Related To Warrants Exercised For Cash
ReclassificationOfWarrantLiabilitiesRelatedToWarrantsExercisedForCash
22625000
nwbo Reclassification Of Warrant Liabilities Related To Warrants Exercised For Cash
ReclassificationOfWarrantLiabilitiesRelatedToWarrantsExercisedForCash
34412000
nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
26800000
nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
1596000
nwbo Reclassification Of Warrant Liabilities Based On Authorized Shares
ReclassificationOfWarrantLiabilitiesBasedOnAuthorizedShares
56114000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
7054000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
7487000
nwbo Issuance Of Convertible Preferred Stock In Lieu Of Debt Redemption
IssuanceOfConvertiblePreferredStockInLieuOfDebtRedemption
1978000
nwbo Exercise Common Stock Warrants By Debt Redemption
ExerciseCommonStockWarrantsByDebtRedemption
277000
nwbo Reclassification Between Shares Payable And Equity
ReclassificationBetweenSharesPayableAndEquity
250000
nwbo Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
4000
nwbo Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
327000
nwbo Capital Expenditures Included In Accounts Payable And Accrued Expenses To Related Parties And Affiliates
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpensesToRelatedPartiesAndAffiliates
559000
nwbo Issuance Of Common Shares To Settle Accrued Service Liability
IssuanceOfCommonSharesToSettleAccruedServiceLiability
73000
us-gaap Net Income Loss
NetIncomeLoss
-76700000
us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
43900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:normal;">On an ongoing basis, the Company evaluates its estimates and judgments, including valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets and whether impairment charges may apply. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the reported amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates, particularly given the significant social and economic disruptions and uncertainties associated with the ongoing coronavirus pandemic (“COVID-19”) and the COVID-19 control responses.</span></p>
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
73650000
CY2022Q3 nwbo Embedded Derivative Redemption Option Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeRedemptionOptionFairValueOfEmbeddedDerivativeLiability
922000
CY2022Q3 nwbo Contingent Payable Derivative Liability
ContingentPayableDerivativeLiability
8012000
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
82584000
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
106784000
CY2021Q4 nwbo Embedded Derivative Redemption Option Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeRedemptionOptionFairValueOfEmbeddedDerivativeLiability
988000
CY2021Q4 nwbo Contingent Payable Derivative Liability
ContingentPayableDerivativeLiability
8232000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
116004000
nwbo Fair Value Liabilities Transfer Between Levels Amount
FairValueLiabilitiesTransferBetweenLevelsAmount
0
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
116004000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
191000
nwbo Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Debt Redemption
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDebtRedemption
-69000
nwbo Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification For Warrants Exercised For Cash
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationForWarrantsExercisedForCash
49425000
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
15883000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
82584000
CY2022Q3 nwbo Amount Recognized And Expensed For Completed Milestones
AmountRecognizedAndExpensedForCompletedMilestones
200000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3361000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1263000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9741000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
56000
us-gaap Variable Lease Cost
VariableLeaseCost
9000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.033
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5400000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
304847000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.33
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
114803000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8005000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.65
nwbo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P7Y
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8187000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
69000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.65
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
304596000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.34
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
114617000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
281963000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
108301000
nwbo Share Based Compensation Arrangement By Share Based Payment Award Period Of Notice For Exercising Any Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOfNoticeForExercisingAnyOption
P61D
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27578000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2391000
CY2022Q3 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
922000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
26109000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
35243000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3836000
CY2021Q4 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
988000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
32395000
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-200000
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
400000
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
400000
CY2022Q3 nwbo Stock Issued During Period Shares In Lieu Of Cash Payments Of Outstanding Debt
StockIssuedDuringPeriodSharesInLieuOfCashPaymentsOfOutstandingDebt
2800000
CY2022Q3 nwbo Repayments Of Debt By Issuance Of Shares
RepaymentsOfDebtByIssuanceOfShares
1700000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32852000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4410000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-76734000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
287000
CY2021Q3 nwbo Reversal Of Gain Due To Change In Fair Value Of Warrant Liability
ReversalOfGainDueToChangeInFairValueOfWarrantLiability
-17500000
nwbo Reversal Of Gain Due To Change In Fair Value Of Warrant Liability
ReversalOfGainDueToChangeInFairValueOfWarrantLiability
-35063000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-32852000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13090000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-76734000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-34776000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1040982
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
875963
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1001703
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
854276
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
75
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
75
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1040982
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1135762
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1001703
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1099598
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
472218000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
313717000
CY2021Q3 nwbo Extended Term Of Agreement
ExtendedTermOfAgreement
P12M
CY2022Q3 nwbo Extended Term Of Agreement
ExtendedTermOfAgreement
P12M
CY2022Q3 nwbo Extended Term Of Agreement
ExtendedTermOfAgreement
P12M
CY2022Q2 nwbo Number Of Required Licenses For Sawston Facility
NumberOfRequiredLicensesForSawstonFacility
3
CY2022Q3 nwbo Number Of Required Licenses For Sawston Facility
NumberOfRequiredLicensesForSawstonFacility
3
nwbo Amount Recognized And Expensed Related To Current Cash Component
AmountRecognizedAndExpensedRelatedToCurrentCashComponent
1500000
nwbo Milestones Costs In Shares
MilestonesCostsInShares
2500000
nwbo Number Of Milestones Completed
NumberOfMilestonesCompleted
3
nwbo Amount Recognized And Expensed Related To Cash Component
AmountRecognizedAndExpensedRelatedToCashComponent
3800000
nwbo Amount Recognized And Expensed Related To Stock Component
AmountRecognizedAndExpensedRelatedToStockComponent
4600000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
37000
us-gaap Sublease Income
SubleaseIncome
110000
nwbo Capitalized Cost Amortization
CapitalizedCostAmortization
28000
nwbo Capitalized Cost Amortization
CapitalizedCostAmortization
1400000
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1400000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.24
CY2022Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
329000
CY2022Q3 nwbo Term By Which Preferred Shares Cannot Be Converted Into Common Stock
TermByWhichPreferredSharesCannotBeConvertedIntoCommonStock
P3M
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1400000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10000000
nwbo Stock Issued During Period Shares Warrant Exercises
StockIssuedDuringPeriodSharesWarrantExercises
40900000
nwbo Debt Instrument Redemption Shares Issued
DebtInstrumentRedemptionSharesIssued
10400000
nwbo Debt Instrument Redemption Amount
DebtInstrumentRedemptionAmount
7000000
nwbo Debt Instrument Redemption Amount Interest
DebtInstrumentRedemptionAmountInterest
1300000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
225469
CY2021Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.30
CY2021 nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P0Y11M15D
nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
42301
nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
0.24
nwbo Number Of Warrants Warrants Cashless Exercise
NumberOfWarrantsWarrantsCashlessExercise
35951
nwbo Weighted Average Exercise Price Warrants Cashless Exercise
WeightedAverageExercisePriceWarrantsCashlessExercise
0.23
nwbo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
1799
nwbo Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
1.58
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
145417
CY2022Q3 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.30
nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P1Y6M7D
nwbo Class Of Warrant Or Right Extended In Suspension
ClassOfWarrantOrRightExtendedInSuspension
142000000
CY2022Q3 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4500000
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P20Y
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4000000.0
us-gaap Operating Lease Cost
OperatingLeaseCost
643000
us-gaap Sublease Income
SubleaseIncome
110000
us-gaap Lease Cost
LeaseCost
598000
us-gaap Operating Lease Payments
OperatingLeasePayments
689000
us-gaap Operating Lease Cost
OperatingLeaseCost
705000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
38000
us-gaap Variable Lease Cost
VariableLeaseCost
53000
us-gaap Lease Cost
LeaseCost
796000
us-gaap Operating Lease Payments
OperatingLeasePayments
603000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
212000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
856000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
762000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
557000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
557000
CY2022Q3 nwbo Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
6663000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9607000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5141000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4466000
nwbo Original Term Of Agreement
OriginalTermOfAgreement
P8M
nwbo Extended Term Of Agreement
ExtendedTermOfAgreement
P12M
CY2022Q3 nwbo Extended Term Of Agreement
ExtendedTermOfAgreement
P12M
CY2022Q3 nwbo Litigation Settlement Waiver Of Penalty
LitigationSettlementWaiverOfPenalty
135000
CY2022Q3 nwbo Litigation Settlement Waiver Of Penalty
LitigationSettlementWaiverOfPenalty
141000
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
377000
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
369000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001410578-22-003073-index-headers.html Edgar Link pending
0001410578-22-003073-index.html Edgar Link pending
0001410578-22-003073.txt Edgar Link pending
0001410578-22-003073-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nwbo-20220930.xsd Edgar Link pending
nwbo-20220930x10q.htm Edgar Link pending
nwbo-20220930xex31d1.htm Edgar Link pending
nwbo-20220930xex32d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
nwbo-20220930_def.xml Edgar Link unprocessable
nwbo-20220930_lab.xml Edgar Link unprocessable
nwbo-20220930_pre.xml Edgar Link unprocessable
nwbo-20220930x10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nwbo-20220930_cal.xml Edgar Link unprocessable